What do we know about Kawasaki disease?
The authors present current theory of the aetiology and pathogenesis of Kawasaki disease with special reference to clinical presentation and cardiac complications. Current therapeutic management has also been discussed.
Kucińska
B
B
Department of Paediatric Cardiology, Medical University, ul. Marszalkowska 24, 00-576 Warsaw, Poland.
Wróblewska-Kałuzewska
M
M
D001241:Aspirin / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000209:etiology; D002675:Child, Preschool; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007223:Infant; D008297:Male; D009080:Mucocutaneous Lymph Node Syndrome / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D011379:Prognosis
D016756:Immunoglobulins, Intravenous; D001241:Aspirin